$5.490
-0.108 (-1.96%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PRLD Prediction & Forecast by Similar Chart Analysis
Alphio's PRLD stock price prediction model matches the current Prelude Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.52 (+0.53%). The 1-week path is $5.69 (+3.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Prelude Therapeutics Inc Stock?
Prelude Therapeutics Inc is a good buy right now due to its current price of $5.47, which is significantly below analyst targets of $9 and $10, indicating potential upside. The company reported a 55% reduction in net loss for Q2, down to $13.92 million, and achieved $5.70 million in revenue, compared to no revenue in the same quarter last year. However, the main risk is the high volatility indicated by an implied volatility of 159.73% and a recent 5-day price change of -17.50%.
PRLD stock price ended at $5.49 on Tuesday, after losing -1.96%
Prelude Therapeutics Inc (PRLD) last closed at $5.49, losing -1.96%. These facts feed the 1-day and 1-week PRLD price prediction above.
Forecast Drivers
Prelude Therapeutics Inc (PRLD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches PRLD, ranked by similarity.
Seasonality analysis for PRLD
Historically the probability of a positive September return for PRLD is 28.57%. August offers the highest probability of a positive month at 71.88%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PRLD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $0.71 | $0.72 | $0.87 | -86.91% |
| Oct 2026 | $0.57 | $0.72 | $0.80 | -86.91% |
| Nov 2026 | $0.76 | $0.83 | $0.88 | -84.86% |
| Dec 2026 | $0.93 | $0.97 | $1.00 | -82.29% |
In 2026, Prelude Therapeutics Inc (PRLD) is projected to range from $0.57 to $1.00.
Prelude Therapeutics Inc 2026 monthly forecast
In Sep 2026, Prelude Therapeutics Inc is projected to average $0.72, with a low of $0.71 and high of $0.87.
In Oct 2026, Prelude Therapeutics Inc is projected to average $0.72, with a low of $0.57 and high of $0.80.
In Nov 2026, Prelude Therapeutics Inc is projected to average $0.83, with a low of $0.76 and high of $0.88.
In Dec 2026, Prelude Therapeutics Inc is projected to average $0.97, with a low of $0.93 and high of $1.00.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.